NEWS
New immunotherapy combo cuts death risk by 58% in small cell lung cancerCombining an innovative immunotherapy with a standard one in advanced small cell lung cancer reduced the risk of death by 58%. This approach offers an unprecedented survival gain when applied before the disease relapses. This is a news summary compiled for the İyi Giden Şeyler newsletter — not the original article. The original article is at lemonde.fr. Read the original article English (automatic translation) |